Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecular 'brake' found for neurofibromatosis 1

26.06.2006
A team led by Duke University Medical Center researchers has identified in yeast a molecular "brake" that could inhibit the proliferation of cells that characterizes neurofibromatosis 1, a common hereditary disorder that causes potentially troublesome tumors along nerve fibers.

This brake is a protein that appears to stop the cascade of molecular events that leads to the activation of a cancer-producing gene, or oncogene, that causes the tumors. The oncogene, called Ras, was one of the first oncogenes ever discovered and has been implicated in more than half of all human cancers.

The new finding could have important medical implications, the researchers said, since the gene involved and the processes that regulate its activation are the same in humans as in yeasts. Similar genes in different species are known as homologs.

The researchers reported their findings in the June 23, 2006, issue of the journal Molecular Cell. The study was supported by the National Institutes of Health, the Children's Tumor Foundation, and the Department of Defense's Neurofibromatosis Foundation.

Neurofibromatosis 1 occurs in about one in 3,500 newborn children and is characterized by multiple growths, or neurofibromas, on or under the skin, usually along nerve fibers. Occasionally, the neurofibromas become large and disfiguring, or develop on the brain or spinal cord. About half of patients with neurofibromatosis 1 have learning disabilities.

The Duke researchers focused their attention on the neurofibromatosis 1 gene, which contains the blueprint for the production of neurofibromin, a protein found primarily in nerve cells. A tumor-suppressor protein, neurofibromin keeps the Ras gene in check and prevents abnormal cell growth.

"We know that patients with neurofibromatosis 1 have defects, or mutations, in the neurofibromin gene," said lead researcher Joseph Heitman, M.D., Ph.D. "As a consequence, the protein it produces becomes unstable and can no longer effectively suppress the Ras oncogene. As a result, Ras becomes over-stimulated, and this in turn leads to the formation of the tumors along the nerve fivers."

Scientists have not fully understood how and why the mutated neurofibromin gene leads to activation of the Ras oncogene. In the current study, the researchers discovered two novel proteins that appear to be necessary in neurofibromin's ability to regulate Ras. The team named these novel proteins Gpb1 and Gbp2.

"When the two proteins are present, they keep the yeast neurofibromin homologs stabilized, effectively blocking the molecular signaling pathway that activates Ras," said Toshiaki Harashima, Ph.D., first author of the study. Harashima, a cell biologist, worked as a senior postdoctoral fellow in Heitman's laboratory and now is at the National Institute for Basic Biology in Japan.

"Our findings add to basic understanding of how neurofibromin is stabilized," Harashima said. "By shedding light on these fundamental processes, we hope we can help in the development of new drugs or therapies to block the activation of Ras and prevent this disease."

According to Heitman, yeast, a member of the fungus family, can serve as an effective model for studying basic molecular processes in humans, beyond those involved in neurofibromatosis 1, because the signaling pathways of many genes are remarkably similar in both types of organisms.

"These processes have remained in the genomes of yeasts and humans over a billion years of evolution," Heitman said. "Now that scientists have mapped the entire genome of the baker's yeast we study, Saccharomyces cerevisiae, we are able to look for human gene equivalents using all the latest experimental methods that have been developed over the years using yeasts."

Richard Merritt | EurekAlert!
Further information:
http://www.mc.duke.edu

More articles from Life Sciences:

nachricht Unique genome architectures after fertilisation in single-cell embryos
30.03.2017 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

nachricht Transport of molecular motors into cilia
28.03.2017 | Aarhus University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

NASA laser communications to provide Orion faster connections

30.03.2017 | Physics and Astronomy

Reusable carbon nanotubes could be the water filter of the future, says RIT study

30.03.2017 | Studies and Analyses

Unique genome architectures after fertilisation in single-cell embryos

30.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>